ADAR1 Capital Management, LLC

CIK: 0001940272

Transaction Breakdown

Open Market Buys (P)64 (84.2%)

High conviction signal

Open Market Sales (S)3 (3.9%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)9 (11.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (5)

NXTC

NextCure, Inc.

10% Owner

TENX

TENAX THERAPEUTICS, INC.

10% Owner

INM

InMed Pharmaceuticals Inc.

10% Owner

RLYB

Rallybio Corp

10% Owner

KROS

Keros Therapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (76 total)

NXTC
NextCure, Inc.
Oct 27, 2026
Purchase(P)
Indirect
3.6K shares at avg. $5.10$18K
NXTC
NextCure, Inc.
Oct 26, 2026
Purchase(P)
Indirect
1.7K shares at avg. $5.03$8K
NXTC
NextCure, Inc.
Oct 23, 2026
Purchase(P)
Indirect
5.6K shares at avg. $4.83$27K
INM
InMed Pharmaceuticals Inc.
Oct 23, 2026
Purchase(P)
Indirect
4 shares at avg. $1.32$5.28
TENX
TENAX THERAPEUTICS, INC.
Oct 21, 2026
Purchase(P)
Indirect
332K shares at avg. $1.66$551K
TENX
TENAX THERAPEUTICS, INC.
Oct 20, 2026
Purchase(P)
Indirect
254.3K shares at avg. $1.60$406K
TENX
TENAX THERAPEUTICS, INC.
Oct 19, 2026
Purchase(P)
Indirect
336.5K shares at avg. $1.51$507K
INM
InMed Pharmaceuticals Inc.
Oct 19, 2026
Purchase(P)
Indirect
1.1K shares at avg. $1.32$1K
INM
InMed Pharmaceuticals Inc.
Oct 16, 2026
Purchase(P)
Indirect
1 shares at avg. $1.32$1.32
INM
InMed Pharmaceuticals Inc.
Oct 15, 2026
Purchase(P)
Indirect
984 shares at avg. $1.32$1K
INM
InMed Pharmaceuticals Inc.
Oct 14, 2026
Purchase(P)
Indirect
8K shares at avg. $1.33$11K
INM
InMed Pharmaceuticals Inc.
Oct 13, 2026
Purchase(P)
Indirect
564 shares at avg. $1.33$750.12
INM
InMed Pharmaceuticals Inc.
Oct 8, 2026
Purchase(P)
Indirect
2.3K shares at avg. $1.33$3K
INM
InMed Pharmaceuticals Inc.
Oct 7, 2026
Purchase(P)
Indirect
3K shares at avg. $1.33$4K
INM
InMed Pharmaceuticals Inc.
Oct 6, 2026
Purchase(P)
Indirect
5.6K shares at avg. $1.33$7K
INM
InMed Pharmaceuticals Inc.
Oct 5, 2026
Purchase(P)
Indirect
18.2K shares at avg. $1.33$24K
INM
InMed Pharmaceuticals Inc.
Oct 2, 2026
Purchase(P)
Indirect
8.3K shares at avg. $1.33$11K
INM
InMed Pharmaceuticals Inc.
Oct 1, 2026
Purchase(P)
Indirect
16.4K shares at avg. $1.33$22K
INM
InMed Pharmaceuticals Inc.
Sep 16, 2026
Purchase(P)
Indirect
8.3K shares at avg. $1.29$11K
INM
InMed Pharmaceuticals Inc.
Sep 15, 2026
Purchase(P)
Indirect
54.3K shares at avg. $1.30$70K
INM
InMed Pharmaceuticals Inc.
Sep 14, 2026
Purchase(P)
Indirect
28.5K shares at avg. $1.29$37K
TENX
TENAX THERAPEUTICS, INC.
Sep 3, 2026
Purchase(P)
Indirect
900K shares at avg. $1.78$1.6M
TENX
TENAX THERAPEUTICS, INC.
Sep 2, 2026
Purchase(P)
Indirect
187.7K shares at avg. $1.80$338K
TENX
TENAX THERAPEUTICS, INC.
Sep 1, 2026
Purchase(P)
Indirect
179.1K shares at avg. $1.80$322K
TENX
TENAX THERAPEUTICS, INC.
Aug 31, 2026
Purchase(P)
Indirect
403.6K shares at avg. $1.79$723K

		Type	Shares	Price		Ownership
Oct 27, 2026	NXTC NextCure, Inc.	Purchase(P)	3,553	$5.10	$18,104	Indirect
Oct 26, 2026	NXTC NextCure, Inc.	Purchase(P)	1,672	$5.03	$8,418	Indirect
Oct 23, 2026	NXTC NextCure, Inc.	Purchase(P)	5,626	$4.83	$27,170	Indirect
Oct 23, 2026	INM InMed Pharmaceuticals Inc.	Purchase(P)	4	$1.32	$5	Indirect
Oct 21, 2026	TENX TENAX THERAPEUTICS, INC.	Purchase(P)	331,979	$1.66	$550,687	Indirect
Oct 20, 2026	TENX TENAX THERAPEUTICS, INC.	Purchase(P)	254,342	$1.60	$405,726	Indirect
Oct 19, 2026	TENX TENAX THERAPEUTICS, INC.	Purchase(P)	336,528	$1.51	$507,013	Indirect
Oct 19, 2026	INM InMed Pharmaceuticals Inc.	Purchase(P)	1,086	$1.32	$1,434	Indirect
Oct 16, 2026	INM InMed Pharmaceuticals Inc.	Purchase(P)	1	$1.32	$1	Indirect
Oct 15, 2026	INM InMed Pharmaceuticals Inc.	Purchase(P)	984	$1.32	$1,301	Indirect
Oct 14, 2026	INM InMed Pharmaceuticals Inc.	Purchase(P)	8,021	$1.33	$10,668	Indirect
Oct 13, 2026	INM InMed Pharmaceuticals Inc.	Purchase(P)	564	$1.33	$750	Indirect
Oct 8, 2026	INM InMed Pharmaceuticals Inc.	Purchase(P)	2,256	$1.33	$2,997	Indirect
Oct 7, 2026	INM InMed Pharmaceuticals Inc.	Purchase(P)	3,046	$1.33	$4,051	Indirect
Oct 6, 2026	INM InMed Pharmaceuticals Inc.	Purchase(P)	5,601	$1.33	$7,436	Indirect
Oct 5, 2026	INM InMed Pharmaceuticals Inc.	Purchase(P)	18,182	$1.33	$24,182	Indirect
Oct 2, 2026	INM InMed Pharmaceuticals Inc.	Purchase(P)	8,307	$1.33	$11,048	Indirect
Oct 1, 2026	INM InMed Pharmaceuticals Inc.	Purchase(P)	16,431	$1.33	$21,850	Indirect
Sep 16, 2026	INM InMed Pharmaceuticals Inc.	Purchase(P)	8,340	$1.29	$10,750	Indirect
Sep 15, 2026	INM InMed Pharmaceuticals Inc.	Purchase(P)	54,256	$1.30	$70,446	Indirect
Sep 14, 2026	INM InMed Pharmaceuticals Inc.	Purchase(P)	28,505	$1.29	$36,880	Indirect
Sep 3, 2026	TENX TENAX THERAPEUTICS, INC.	Purchase(P)	900,000	$1.78	$1,604,160	Indirect
Sep 2, 2026	TENX TENAX THERAPEUTICS, INC.	Purchase(P)	187,704	$1.80	$337,586	Indirect
Sep 1, 2026	TENX TENAX THERAPEUTICS, INC.	Purchase(P)	179,058	$1.80	$321,570	Indirect
Aug 31, 2026	TENX TENAX THERAPEUTICS, INC.	Purchase(P)	403,571	$1.79	$722,594	Indirect

1-25 of 76 transactions

About ADAR1 Capital Management, LLC

ADAR1 Capital Management, LLC (SEC CIK 0001940272) files insider reports with the SEC as 10% Owner of NextCure, Inc. (NXTC), 10% Owner of TENAX THERAPEUTICS, INC. (TENX) and 10% Owner of InMed Pharmaceuticals Inc. (INM). Signal8 also holds filings tied to 2 other companies.

Signal8 holds 28 ownership filings by ADAR1 Capital Management, LLC (5 Form 3, 23 Form 4), filed between Apr 11, 2025 and Oct 27, 2026. Those filings report 76 transactions, from Apr 9, 2025 to Oct 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on ADAR1 Capital Management, LLC's filings is in AUSTIN, TX.

Recent filings by ADAR1 Capital Management, LLC

Oct 27, 2026: Open-market purchase of NXTC shares (Form 4, code P).
Oct 26, 2026: Open-market purchase of NXTC shares (Form 4, code P).
Oct 23, 2026: Open-market purchase of NXTC shares (Form 4, code P).
Oct 23, 2026: Open-market purchase of INM shares (Form 4, code P).
Oct 21, 2026: Open-market purchase of TENX shares (Form 4, code P).

Other insiders filing for NextCure, Inc. (NXTC)

How to read Form 4 transaction codes